At-the-Money Calls on Sun Pharmaceutical Industries Ltd Draw 7,735 Contracts — A Signal of Immediate Directional Conviction

Options Event and Cash Market Price Action

The most active call options on Sun Pharmaceutical Industries Ltd on 7 July 2026 were the Rs 1,920 strike with 4,056 contracts traded and the Rs 1,940 strike with 3,679 contracts. The total turnover for these strikes was approximately ₹81.1 crores, reflecting significant monetary flow into call options. The underlying stock closed at Rs 1,910.7, just below the Rs 1,920 strike, indicating that the Rs 1,920 calls are at-the-money (ATM), while the Rs 1,940 calls are slightly out-of-the-money (OTM).

The expiry date for these options is 28 July 2026, giving traders just over three weeks to capitalise on their positions. The proximity of expiry suggests a relatively short-term directional bet, with the options market anticipating movement within this timeframe. The stock’s 0.54% gain on the day, outperforming the sector’s 0.30% rise and the Sensex’s 0.71% decline, aligns with the bullish tone in the derivatives market — is this a momentum play worth joining or has the easy move already happened?

Strike Price and Moneyness Analysis

The Rs 1,920 strike price is effectively at-the-money given the stock’s closing price of Rs 1,910.7, making these calls highly sensitive to immediate price fluctuations. At-the-money options typically reflect a bet on near-term directional movement rather than distant targets, as their gamma—the rate of change of delta—is highest. The Rs 1,940 strike calls, being slightly out-of-the-money, represent a speculative upside bet, signalling expectations of the stock surpassing this level before expiry.

The selection of these strikes reveals a nuanced positioning: the Rs 1,920 calls suggest traders are anticipating a move around the current price level, while the Rs 1,940 calls imply a modestly bullish outlook with a target approximately 1.5% above the current price. This dual strike activity indicates a layered approach to directional conviction — what does the strike price selection reveal about the nature of the bet?

Open Interest and Contracts Analysis

Open interest (OI) at the Rs 1,920 strike stands at 3,256 contracts, while the Rs 1,940 strike has an OI of 1,977 contracts. Comparing these figures with the day’s traded contracts—4,056 and 3,679 respectively—yields contracts-to-OI ratios of approximately 1.25:1 and 1.86:1. Ratios above 1 indicate that the volume traded on the day exceeds the existing open interest, signalling fresh positioning rather than mere rollovers or position squaring.

This surge in fresh call buying at these strikes, especially near expiry, points to a strong directional intent. The Rs 1,940 strike’s higher ratio suggests more speculative new money entering at this slightly out-of-the-money level. The open interest levels themselves are substantial, indicating that these are not isolated trades but part of a broader established interest in these strikes — does this fresh positioning signal sustained momentum or a short-lived spike?

Cash Market Context: Price Momentum and Moving Averages

Sun Pharmaceutical Industries Ltd is trading comfortably above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical backdrop supports the bullish options activity, as the stock’s upward momentum is well established. The recent new 52-week high of Rs 1,929.5 further confirms the strength in the underlying price action.

Investor participation is also rising, with delivery volumes on 7 July reaching 12.27 lakh shares, a 30.58% increase over the five-day average. This rise in delivery volume alongside call option activity suggests that the derivatives market’s bullish positioning is being matched by genuine cash market interest — buy, sell, or hold Sun Pharmaceutical Industries Ltd? The multi-factor analysis resolves the contradiction.

Delivery Volume and Liquidity Considerations

The delivery volume of 12.27 lakh shares on 7 July, up 30.58% from the recent average, indicates robust participation in the cash market. This increase in delivery volume alongside rising call option activity suggests that the derivatives market’s bullish positioning is supported by genuine investor interest in the underlying shares. The stock’s liquidity, with a trade size capacity of approximately ₹6.51 crores based on 2% of the five-day average traded value, ensures that these moves are not easily distorted by illiquidity.

Such alignment between delivery volumes and options activity strengthens the interpretation that the market is positioning for continued upward movement in the near term — is this a confirmation of sustained momentum or a prelude to consolidation?

Key Data at a Glance

Conclusion: What the Options and Cash Data Collectively Signal

The heavy call option activity at the Rs 1,920 and Rs 1,940 strikes on Sun Pharmaceutical Industries Ltd reflects a clear directional positioning focused on near-term upside. The at-the-money Rs 1,920 calls indicate a bet on immediate price movement, while the slightly out-of-the-money Rs 1,940 calls suggest a modestly bullish target. The contracts-to-open-interest ratios above 1 confirm fresh money entering these strikes rather than mere position adjustments.

Supporting this, the stock’s price action is robust, trading above all major moving averages and hitting a new 52-week high. Rising delivery volumes further corroborate the bullish sentiment, indicating that the derivatives market’s optimism is mirrored in the cash market. However, with expiry just weeks away, the urgency of these bets is palpable — should this be viewed as a momentum play worth joining or a peak in short-term enthusiasm?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →